YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

The Research Regarding a Prevention Effect of Osteoprosis used an Arrowroot Fermentation from Ovaryectomized SD Rat

난소적출 흰쥐를 이용한 칡 발효액이 골다공증 예방 효과에 미치는 영향 연구

  • Published : 2005.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

In our study, osteoporosis was induced by ovariectomized in female Sprague-Daweley rats, and the prevention and treatment efficacy of the climacteric disease the postmenopausal Type I pattern was examined by using the experimental substance soybeans and arrowroot. After ovariectomy; the amount of estrogen was found to be reduced by 21.37$\%$ and it showed the tendency to be increased by 4.49$\%$ in T1 (extraction of soybeans group) and 7.62$\%$ in T2 (extraction of ferment soybeans group). The change of bone density, 14 weeks after ovariectomy in the femur, was decreased by 9.33$\%$ in N.C. group, and 5.46$\%$ in T3 (extraction of ferment arrowroot group). As pathological findings, the trabeculae of femur were detected to be abundant as normal and the frequency of the appearance of osteoclasts was very minimal. In the T3, the frequency of the appearance of the trabeculae of femur was increased to the level that could be distinguished. In regard to the accumulation of lipid in the bone marrow, the accumulation of lipid in the bone marrow was low as normal. However, in T3, the decrease to the level that could be distinguished was detected. In addition, in regard to the pathological findings of the uterus, normal uterine tissue findings were detected. In the T3, the minimal atrophy findings were detected. In conclusion, when the T3 was orally administered continuously for 14 weeks, it was thought that a certain proportion of the hormonal balance was maintained that functioned as a substance interfering the accumulation of fat, and it was considered to be of help in the treatment of not only osteoporosis Type I, but also for the prevention and treatment of various endocrinal diseases.

Keywords

References

  1. Editorial Committee. Korean Pharmacopoeia. 7th ed. pp. 721-988. Korean Medical Index Press, Seoul, Korea (1998)
  2. Faculities in Department of Herbology. Oriental Herbology. pp. 242-244, 167-168. Young-Lim Publishing Co., Seoul (1991)
  3. Kurihara, T. and Kikuchi, M. : Studies on the constituents of flowers. IV. On the components of the flower of Pueraria thubergiana Benth. (3). Yakugaku Zasshi. 96, 1486 (1976)
  4. Lee, K. T., Sohn, I. C., Kong, E. A., Kim, D. H., Choi, S. K., Choi, J. W. and Park, H. J. : Antioxidative and cytoprotective effects of isoflavones isolated from Pueraria thunbergiana flowers. Yakhak Hoeji 43, 736 (1999)
  5. Kinjo, J., Takeshita, T., Abe, Y., Terada, N., Yamashita, H., Yamasaki, M., Takeuchi, K., Murasaki, K., Tomimatsu, T. and Nohara, T. : Studies on the constituents of pueraria lobata. IV. Chemical constituents in the flowers and the leaves. Chem. Pham. Bull. 36, 1174 (1988) https://doi.org/10.1248/cpb.36.1174
  6. Consensus Conference. Osteoporosis. JAMA 252, 799 (1984) https://doi.org/10.1001/jama.252.6.799
  7. Ryan, P. J., Evans, P., Gibson, T. and Fogelman, I. : Osteoporosis and chronic back pain: A study with single-photon emission computed tomography bone scintigraphy. J. Bone Miner. Res. 7, 1455 (1992) https://doi.org/10.1002/jbmr.5650071213
  8. Spencer, H., Rubio, N., Rubio, E., Indreika, M. and Seitam, A. : Chronic alcoholism: Frequently overlooked cause of osteoporosis in men. Am. J. Med. 80, 393 (1986) https://doi.org/10.1016/0002-9343(86)90712-6
  9. Wang, W., Tanaka, Y., Han, E. and Higuchi, C. M. : Proliferative response of mammary glandular tissue to formononetin. Nutr. Cancer 23, 131 (1995) https://doi.org/10.1080/01635589509514369
  10. Saloniemi, H., Wahala, K., Nykanen-Kurki, P., Kallela, K. and Saastamoinen, I. : Phytoestrogen content and estrogenic effect of legume fodder. Proc. Soc. Exp. BioI. Med. 208, 13 (1995)
  11. Bingham, S. A., Atkinson, C., Liggins, J., Bluck, A. and Coward, A. : Phytoestrogens; where are we now? Brit. J. Nutr. 79, 393 (1998) https://doi.org/10.1079/BJN19980068
  12. Evans, G. L., Bryant, H. U., Magee, D. E. and Tuner, R. T. : Raloxifene inhibits bone turn over and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia. Endocrinology 137, 4139 (1996) https://doi.org/10.1210/en.137.10.4139
  13. Bryant, H. U. and Dere, W. H. : Selective estrogen receptor modulators: an alternative to hormone replacement therapy. Proc. Soc. Exp. Bio. Med. 217, 45 (1998)
  14. Scrip Reports, Dsteoporosis: research, markets, trends and opportunities. PJB Publications Ltd. pp.57-84 (1994)
  15. Bergkvist, L., Adami, H.-O., Persson, I., Hoover, R. and Schairer, C. : The risk of breast cancer after estrogen and estrogen-progestin replacement. N. Engl. J. Med. 321, 293 (1989) https://doi.org/10.1056/NEJM198908033210505
  16. Nordin, B. E., Heyburn, P. J., Peacock, M. et al. : Osteoporosis and osteomalacia. Clin Endocrinol. Metab. 9(1), 177 (1980) https://doi.org/10.1016/S0300-595X(80)80026-0
  17. Fotsis, T., Pepper, M., Adlercreutz, H., Flerischmann, G., Hase, T., Montesano, R. and Schweigerer, L. : Genistein a dietary derived inhibition of in vitro angiogenesis. proc. Natl. Acad. Sci. USA 90, 2690 (1993)
  18. Forman, D. and Moller, H. : Testicular cancer. Cancer Survey 19-20, 323 (1994)
  19. Sharpe, R. M. and Skakkebaek, N. E.: Are oestrogen involved falling sperm counts and disorders of the male reproductive tract. Lancet 341, 1392 (1993) https://doi.org/10.1016/0140-6736(93)91076-X
  20. Wolff, M. S. and Weston, A. : Breast cancer risk and environmental exposure. Environmental Health Perspectioes 105, 891 (1977)
  21. Waynforth, H. B. and Flecknell, P. A. : Experimental and Surgical Techniques in the Rat. Academic press (1992)